A simple approach to the estimation of incidence rate difference

American Journal of Epidemiology

Volumn 172, Issue 3, 2010, Pages 334-343

  Xu, Ying ^a   Cheung, Y B ^a,b   Lam, K F ^c   Tan, S H ^d   Milligan, Paul ^e  

^a SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

incidence rate; least squares analysis; recurrent events; standard error

Indexed keywords

PLACEBO; PNEUMOCOCCUS VACCINE;

DISEASE CONTROL; ERROR ANALYSIS; ESTIMATION METHOD; LEAST SQUARES METHOD; NUMERICAL MODEL; PARAMETERIZATION; PERFORMANCE ASSESSMENT; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; VACCINATION;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; HUMAN; INCIDENCE RATE DIFFERENCE; MAJOR CLINICAL STUDY; PNEUMONIA; REGRESSION ANALYSIS; SIMULATION; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; GAMBIA; HUMANS; INCIDENCE; LEAST-SQUARES ANALYSIS; MODELS, BIOLOGICAL; VACCINATION;

EID: 77955166368     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq099     Document Type: Article

References (22)

1. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7): 702-706.
2. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200.
3. Cheung YB. A modified least-squares regression approach to the estimation of risk difference. Am J Epidemiol. 2007; 166(11):1337-1344.
4. Greenwood B. Interpreting vaccine efficacy. Clin Infect Dis. 2005;40(10):1519-1520.
5. Cheung YB, Zaman SM, Ruopuro ML, et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health. 2008;13(5):603-611.
6. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310(6977): 452-454.
7. Cheung YB, Xu Y, Tan SH, et al. Estimation of intervention effects using first or multiple episodes in clinical trials: the Andersen-Gill model re-examined. Stat Med. 2010;29(3): 328-336.
8. Moorthy VS, Reed Z, Smith PG. MALVAC 2008: measures of efficacy of malaria vaccines in phase 2b and phase 3 trials\scientific, regulatory and public health perspectives. Vaccine. 2009;27(5):624-628.
9. Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown and Company; 1986.
10. Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ. 1996;312(7027):364-367.
11. Stukel TA, Glynn RJ, Fisher ES, et al. Standardized rates of recurrent outcomes. Stat Med. 1994;13(17):1781-1791.
12. Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160(4): 301-305.
13. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
14. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometr-ica. 1980;48(4):817-830.
15. Long JS, Ervin LH. Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat. 2000; 54(3):217-224.
16. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403-409.
17. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomized, double-blinded, placebo-controlled trial. Lancet. 2005; 365(9465):1139-1146.
18. Enwere G, Cheung YB, Zaman SM, et al. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007; 12(11):1377-1385.
19. Cameron AC, Trivedi PK. Regression Analysis of Count Data. Cambridge, United Kingdom: Cambridge University Press; 1998.
20. Spiegelman D, Hertzmark E. The authors reply [re: "easy SAS calculations for risk or prevalence ratios and differences"] [letter]. Am J Epidemiol. 2006;163(12):1159-1161.
21. Stata Corporation. Stata Statistical Software, Release 9. College Station, TX: Stata Corporation; 2005.
22. Kelly PJ, Lim LL. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med. 2000;9(1):13-33.